Donna Felsenstein: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (Text replacement - " \| ?last(.*)\=(.*)( *)\| ?first(.*)\=(.*)( *)\| ?author" to " |last$1=$2 |first$3$4 |author") |
Notjusttired (talk | contribs) m (Text replacement - " author-link10=" to " author-link10 = ") |
||
| (135 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{NeedsImage}} | {{NeedsImage}} | ||
'''Donna Felsenstein''', M.D., is an Internal Medicine and Infectious Disease physician who practices at the Massachusetts General Hospital, Boston, MA, US<ref name=":0" /> and is a Assistant Professor of Medicine at Harvard Medical School and Massachusetts General Hospital (MGH)'''.'''<ref name=":1">{{Cite web | url = https://www.omf.ngo/collaborative-research-center-harvard/ | title = ME/CFS Collaborative Research Center at Harvard, funded by OMF|website=Open Medicine Foundation|language=en-US|access-date=2019-09-03}}</ref> She serves as a member of the scientific team with the Open Medicine Foundation.<ref name=":1" /> Since 1979, she has been diagnosing and caring for patients with ME/CFS.<ref name=":1" /> Her listed specialities include [[Lyme disease]], Infectious diseases, and [[Herpes simplex virus]].<ref name=":0">{{Cite web | url = https://www.massgeneral.org/doctors/doctor.aspx?id=16629 | title = Donna Felsenstein, MD - Infectious Diseases - Massachusetts General Hospital, Boston, MA | website = massgeneral.org|access-date=2019-09-03}}</ref> | |||
'''Donna Felsenstein''', M.D., is an Internal Medicine and Infectious Disease physician who practices at the Massachusetts General Hospital, Boston, MA, US<ref name=":0" /> and is a Assistant Professor of Medicine at Harvard Medical School and Massachusetts General Hospital (MGH)'''.'''<ref name=":1">{{Cite web|url=https://www.omf.ngo/collaborative-research-center-harvard/|title=ME/CFS Collaborative Research Center at Harvard, funded by OMF|website=Open Medicine Foundation|language=en-US|access-date=2019-09-03}}</ref> She serves as a member of the scientific team with the Open Medicine Foundation.<ref name=":1" /> Since 1979, she has been diagnosing and caring for patients with ME/CFS.<ref name=":1" /> Her listed specialities include [[Lyme disease]], Infectious diseases, and [[Herpes simplex virus]].<ref name=":0">{{Cite web|url=https://www.massgeneral.org/doctors/doctor.aspx?id=16629|title=Donna Felsenstein, MD - Infectious Diseases - Massachusetts General Hospital, Boston, MA|website= | |||
==Notable studies== | ==Notable studies== | ||
* 2010, Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions<ref>{{Cite journal|last=Henrich|first=Timothy J.| | * 2010, Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions<ref>{{Cite journal | last = Henrich | first = Timothy J. | authorlink = | last2 = Li | first2 = Jonathan Z. | authorlink2 = | last3 = Felsenstein | first3 = Donna | authorlink3 = Donna Felsenstein | last4 = Kotton | first4 = Camille N. | author-link4 = | last5 = Plenge | first5 = Robert M. | author-link5 = | last6 = Pereyra | first6 = Florencia | author-link6 = | last7 = Marty | first7 = Francisco M. | last8 = Lin | first8 = Nina H. | last9 = Grazioso | first9 = Paul | date = 2010-11-15 | title = Xenotropic Murine Leukemia Virus–Related Virus Prevalence in Patients with Chronic Fatigue Syndrome or Chronic Immunomodulatory Conditions |url =https://academic.oup.com/jid/article-lookup/doi/10.1086/657168|journal=The Journal of Infectious Diseases|language=en|volume=202|issue=10 | pages = 1478–1481|doi=10.1086/657168|issn=0022-1899|pmc=2957553|pmid=20936980|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957553/ (Full text)] | ||
* 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness<ref>{{Cite journal|last1=Hornig|first1=M| | * 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness<ref>{{Cite journal | last1 = Hornig | first1 = M | authorlink = Mady Hornig | last2 = Montoya | first2 = JG | authorlink2 = Jose Montoya | last3 = Klimas | first3 = NG | authorlink3 = Nancy Klimas | last4 = Levine | first4 = SM | authorlink4 = Susan Levine | last5 = Felsenstein | first5 = D | authorlink5 = Donna Felsenstein | last6 = Bateman | first6 = L | author-link6 = Lucinda Bateman | last7 = Peterson | first7 = DL | author-link8 = Daniel Peterson | last8 = Gottschalk | first8 = CG | author-link8 = Gunnar Gottschalk | last9 = Schultz|first9 = AF | author-link9 = Andrew Schultz | last10 = Che | first10 = X | author-link10 = Xiaoyu Che | last11 = Eddy | first11 = ML | author-link11 = Meredith Eddy | last12 = Komaroff | first12 = AL | author-link13 = Anthony Komaroff | last13 = Lipkin | first13 = WI | author-link13 = Ian Lipkin | title = Distinct plasma immune signatures in ME/CFS are present early in the course of illness|journal=Science Advances|volume=1|issue=1| page = | date = 2015 | pmid = |doi =10.1126/sciadv.1400121 | url = http://advances.sciencemag.org/content/1/1/e1400121.full}}</ref> - [https://advances.sciencemag.org/content/1/1/e1400121 (Full text)] | ||
*2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome<ref name="KlimasNG, 2015" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1023652 (Abstract)] | *2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome<ref name="KlimasNG, 2015" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1023652 (Abstract)] | ||
| Line 26: | Line 25: | ||
==References== | ==References== | ||
<references> | <references> | ||
<ref name="KlimasNG, 2015">{{Citation |last1 | <ref name="KlimasNG, 2015">{{Citation | last1 = Klimas | first1 = N.G. | author-link1 = Nancy Klimas | last2 =Ironson | first2 = G. | authorlink2 = | last3 = Carter | first3 = A. | authorlink3 = | last4 = Balbin | first4 = E. | authorlink4 = Elizabeth Balbin | last5 = Bateman | first5 = L. | authorlink5 = Lucinda Bateman | last6 = Felsenstein | first6 =D. | author-link6 = Donna Felsenstein | last7 = Levine | first7 = S. | author-link8 = Susan Levine | last8 =Peterson | first8 =D. | author-link8 = Daniel Peterson | last9 = Chiu | first9 = K. | author-link9 = | last10 = Allen | first10 = A. | author-link10 = | last11 = Cunningham | first11 = K. | author-link11 = | last12 = Gottschalk | first12 = C.G. | author-link12 = Gunnar Gottschalk | last13 = Fletcher | first13 = M | author-link13 = Mary Ann Fletcher | last14 = Hornig | first14 = M. | author-link14 = Mady Hornig | last15 = Canning | first15 = C. | author-link15 = | last16 = Komaroff | first16 = A.L. | author-link16 = Anthony Komaroff | title = Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome | journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 2| page = 75-96 | date = 2015 | pmid = | doi = 10.1080/21641846.2015.1023652 }}</ref> | ||
| title | |||
| journal = Fatigue: Biomedicine, Health & Behavior | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
</references> | </references> | ||
[[Category:Researchers]] | [[Category:Researchers]] | ||
Latest revision as of 16:54, April 2, 2023
Donna Felsenstein, M.D., is an Internal Medicine and Infectious Disease physician who practices at the Massachusetts General Hospital, Boston, MA, US[1] and is a Assistant Professor of Medicine at Harvard Medical School and Massachusetts General Hospital (MGH).[2] She serves as a member of the scientific team with the Open Medicine Foundation.[2] Since 1979, she has been diagnosing and caring for patients with ME/CFS.[2] Her listed specialities include Lyme disease, Infectious diseases, and Herpes simplex virus.[1]
Notable studies[edit | edit source]
- 2010, Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions[3] - (Full text)
- 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness[4] - (Full text)
- 2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome[5] - (Abstract)
Clinic location[edit | edit source]
55 Fruit St, Boston, MA 02114
Phone: (617) 726-3812
Talks and interviews[edit | edit source]
- 8 June 2019, Clinician Panel Discussion on ME/CFS, given at the Inaugural Harvard ME/CFS Collaboration Symposium sponsored by Open Medicine Foundation
- 17 November 2020, https://www.youtube.com/watch?v=quUTD4v-9lc&t=9s&ab_channel=MassMECFS%26FM, Massachusetts ME/CFS & FM Association http://www.massmecfs.org/ and Open Medicine Foundation Fall 2020 Event on Zoom
Online presence[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ 1.0 1.1 "Donna Felsenstein, MD - Infectious Diseases - Massachusetts General Hospital, Boston, MA". massgeneral.org. Retrieved September 3, 2019.
- ↑ 2.0 2.1 2.2 "ME/CFS Collaborative Research Center at Harvard, funded by OMF". Open Medicine Foundation. Retrieved September 3, 2019.
- ↑ Henrich, Timothy J.; Li, Jonathan Z.; Felsenstein, Donna; Kotton, Camille N.; Plenge, Robert M.; Pereyra, Florencia; Marty, Francisco M.; Lin, Nina H.; Grazioso, Paul (November 15, 2010). "Xenotropic Murine Leukemia Virus–Related Virus Prevalence in Patients with Chronic Fatigue Syndrome or Chronic Immunomodulatory Conditions". The Journal of Infectious Diseases. 202 (10): 1478–1481. doi:10.1086/657168. ISSN 0022-1899. PMC 2957553. PMID 20936980.
- ↑ Hornig, M; Montoya, JG; Klimas, NG; Levine, SM; Felsenstein, D; Bateman, L; Peterson, DL; Gottschalk, CG; Schultz, AF; Che, X; Eddy, ML; Komaroff, AL; Lipkin, WI (2015). "Distinct plasma immune signatures in ME/CFS are present early in the course of illness". Science Advances. 1 (1). doi:10.1126/sciadv.1400121.
- ↑ Klimas, N.G.; Ironson, G.; Carter, A.; Balbin, E.; Bateman, L.; Felsenstein, D.; Levine, S.; Peterson, D.; Chiu, K.; Allen, A.; Cunningham, K.; Gottschalk, C.G.; Fletcher, M; Hornig, M.; Canning, C.; Komaroff, A.L. (2015), "Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome", Fatigue: Biomedicine, Health & Behavior, 3 (2): 75-96, doi:10.1080/21641846.2015.1023652
